The inaugural NC Biotech Innovation & Investment Summit (NC-BIIS 2026) opened a new chapter for the North Carolina biopharmaceutical community. Organized in just 49 days — dubbed "North Carolina speed" — the summit drew on 40 years of accumulated professional strength from SAPA members. Nobel Laureate Dr. Gregg L. Semenza delivered a keynote on targeting hypoxia-inducible factors for cancer and eye disease therapies, while CAS Foreign Member Dr. Xiaofan Wang closed the summit with strategic insights on China's pharma "inflection point" and the imperative for US-China collaboration. The event aligned industry, investment, and talent through startup showcases, capital matching sessions, and a dedicated career forum. SAPA-NC President Dr. Bin Xiao articulated a vision of bridging the gap between academia and industry in the Research Triangle's thriving life sciences ecosystem.